Yamada NT, Karasawa T, Wakiya, et al
China has the most individuals with type 2 diabetes, while the US has the second most
How the Program Works GLP-1 receptor agonists are among the most effective medications for weight management currently available
Inflammation may help explain how GLP-1 drugs prevent AFib New research presented at Heart Rhythm 2026 suggests taking GLP-1 receptor agonists (GLP-1-RAs) may reduce the risk of atrial fibrillation (AFib) and improve survival through mechanisms that extend beyond weight loss alone
If you are comparing specific options, a clinician can review your history and current meds, then help you narrow choices and discuss safety considerations
Fatigue associated with Mounjaro is often temporary and may resolve as the body adjusts to the medication, says Shopana Ganpath, MD, an internist with IntraCare Health Center in Grapevine, Texas